Marc-Oliver Turgeon

Marc-Olivier is a Senior Associate at Forbion where he invests and builds companies across therapeutic areas and modalities. He was part of the team that helped build Tessellate Bio and holds an observer role on the board of Pheon Therapeutics. Prior to Forbion, Marc completed his PhD in Oncology at The Institute of Cancer Research in London, where he investigated the interactions between metabolic changes and DNA repair mechanisms in breast cancer. Marc-Olivier also completed his MSc at McGill University, studying neuroendocrine thyroid hormone regulation. As part of his MSc and PhD, he published research in multiple leading journals including Nature, Nature Communications, and Endocrinology.